Stabilen Bakteriellen Extrakten als Arzneimittel
EP4721819
8. April 2026
Anmelder: OM Pharma SA 🇨🇭
Details
- Veröffentlichungs-Nr.
- EP4721819
- Anmeldetag
- 12. März 2020
- Veröffentlichung
- 8. April 2026
- Rechtsraum
- EP
- IPC
- A61P37/00(OM PHARMA et al.)(UNIV TEXAS et al.)
Abstract
The present invention relates to novel stable bacterial extract preparations having substantial increased stability overtime, novel methods of preparation thereof, pharmaceutical formulations based on these novel stabilized bacterial extracts, as well as novel routes of administration and delivery devices for treating and/or preventing acute and chronic immunological disorders resulting from infections and/or inflammation and/or neoplasms and/or dysbiosis.
Anmelder
- Firma
- OM Pharma SA
- Land
- 🇨🇭 Schweiz
Vertreten von
Lecca, Patricia S
Vitry-sur-Seine, Frankreich
253
Patente gesamt
22
Fachgebiete
14
Anmelder-Länder
Schwerpunkte